Yu, J., Chen, X., Cao, G., Pan, Q., Huang, C., Luo, R., . . . Cao, H. (2025). Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply. Alimentary Pharmacology & Therapeutics, 61(2), 377. https://doi.org/10.1111/apt.18392
Chicago Style (17th ed.) CitationYu, Jiong, et al. "Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply." Alimentary Pharmacology & Therapeutics 61, no. 2 (2025): 377. https://doi.org/10.1111/apt.18392.
MLA (9th ed.) CitationYu, Jiong, et al. "Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 61, no. 2, 2025, p. 377, https://doi.org/10.1111/apt.18392.
Warning: These citations may not always be 100% accurate.
